60/100B82.385
USD
-1.36
(-1.62%)
Post Trading·82.380USD-0.005(-0.01%)
Fair value76.47Plus+8%51Price 82.39119
Q4 FY2026 · Earnings report
EPS estimate 1.55Revenue estimate 5.92B
Q4 FY2026 · Earnings report
EPS estimate 1.55Revenue estimate 5.92B
GE HealthCare Technologies current ratioWhat is the current ratio? The current ratio is current assets divided by current liabilities: whether what a company will turn into cash within a year covers what it owes within a year.
GE HealthCare Technologies's current ratio is 1.30: current assets of 11.50B USD against current liabilities of 8.82B USD due within a year.
- Today
- 1.30
- Average, 5 years
- 1.11
- Low, 5 years
- 0.94
- High, 5 years
- 1.30
Current ratio = current assets ÷ current liabilities = 11.50B ÷ 8.82B = 1.30
Current ratio
Total current assets
Total current liabilities
Current assets over current liabilities at each quarter end: above 1, what falls due within a year is covered by what turns into cash within a year.
Current ratio by year and by quarter
| Fiscal year | Period ending | Current ratio | Total current assets | Total current liabilities |
|---|---|---|---|---|
| Today | 1.30 | 11.50B | 8.82B | |
| FY2025 | 31 Dec 2025 | 1.18 | 10.70B | 9.11B |
| FY2024 | 31 Dec 2024 | 1.00 | 9.52B | 9.55B |
| FY2023 | 31 Dec 2023 | 1.00 | 9.01B | 8.98B |
| FY2022 | 31 Dec 2022 | 1.09 | 7.82B | 7.19B |
| FY2021 | 31 Dec 2021 | 0.97 | 6.54B | 6.76B |
| FY2020 | 31 Dec 2020 | 0.84 | 5.45B | 6.52B |
| FY2019 | 31 Dec 2019 | — | — | — |
| Quarter | Period ending | Current ratio | Total current assets | Total current liabilities |
|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 1.30 | 11.50B | 8.82B |
| Q2 FY2026 | 30 Jun 2026 | 1.02 | 8.47B | 8.30B |
| Q1 FY2026 | 31 Mar 2026 | 1.17 | 9.98B | 8.53B |
| Q4 FY2025 | 31 Dec 2025 | 1.18 | 10.70B | 9.11B |
| Q3 FY2025 | 30 Sept 2025 | 1.18 | 11.89B | 10.07B |
| Q2 FY2025 | 30 Jun 2025 | 1.12 | 10.92B | 9.75B |
| Q1 FY2025 | 31 Mar 2025 | 0.94 | 9.38B | 9.97B |
| Q4 FY2024 | 31 Dec 2024 | 1.00 | 9.52B | 9.55B |
| Q3 FY2024 | 30 Sept 2024 | 1.19 | 10.28B | 8.67B |
| Q2 FY2024 | 30 Jun 2024 | 1.01 | 8.44B | 8.32B |
| Q1 FY2024 | 31 Mar 2024 | 1.01 | 8.99B | 8.86B |
| Q4 FY2023 | 31 Dec 2023 | 1.00 | 9.01B | 8.98B |
| Q3 FY2023 | 30 Sept 2023 | 1.20 | 9.08B | 7.57B |
| Q2 FY2023 | 30 Jun 2023 | 1.17 | 8.84B | 7.58B |
| Q1 FY2023 | 31 Mar 2023 | 1.12 | 9.21B | 8.24B |
| Q4 FY2022 | 31 Dec 2022 | 1.09 | 7.82B | 7.19B |
| Q3 FY2022 | 30 Sept 2022 | — | — | — |
| Q2 FY2022 | 30 Jun 2022 | — | — | — |
| Q1 FY2022 | 31 Mar 2022 | — | — | — |
| Q4 FY2021 | 31 Dec 2021 | — | — | — |
| Q3 FY2021 | 30 Sept 2021 | — | — | — |
| Q2 FY2021 | 30 Jun 2021 | — | — | — |
| Q1 FY2021 | 31 Mar 2021 | — | — | — |
Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.
See also:P/E ratio,Market cap,P/S ratio,Dividend yield,ROE (return on equity),Debt to equity,All ratios
Common questions about GE HealthCare Technologies's current ratio
Source: Financial Modeling Prep